Rick Simpson Oil (RSO) in Garland County, Arkansas: The Complete Guide by OilWell Cannabis

If you’re searching for Rick Simpson Oil in Garland County, Arkansas, you’re not alone. From retirees in Hot Springs seeking relief from arthritis and chronic pain to veterans in Malvern managing PTSD, to cancer patients across Garland County looking for supportive options during chemotherapy — the interest in real, scientifically grounded RSO education has never been greater. We created this guide because Garland County residents deserve more than hype and mystery. You deserve the full story: where RSO came from, what the science actually says, and how a modern, legal, multi-cannabinoid formula can fit into your life here in the Natural State.

Garland County’s unique character shapes how we approach this education. Our community is built on healing traditions — Hot Springs National Park has drawn people seeking therapeutic relief for over a century. We understand that many of you have been failed by conventional medicine, facing long specialist wait times, prescription cycles that don’t work, or the harsh reality of the opioid crisis that has touched too many Arkansas families. We’ve designed this content specifically for Garland County’s context: conservative laws requiring careful legal navigation, a population that values natural remedies but demands scientific honesty, and a geography that makes access to specialized care challenging.

This isn’t a sales pitch. This is the most comprehensive RSO education resource available anywhere — and we’re publishing it for Garland County because your community has earned a reputation for asking the right questions and demanding real answers. We’ll cover everything: Rick Simpson’s original story, why traditional RSO fell short, how our seven-cannabinoid formula evolved from a decade of saving a paralyzed dog named Bentley, why the THCa legal framework matters for Arkansas residents, exact product specifications you can verify, and the peer-reviewed research behind every compound. Every claim is cited. Every formula is open-source. Nothing is hidden.

Who is Rick Simpson (And Why Garland County Residents Should Care)

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical researcher — he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with a research grant but with personal suffering after the medical system failed him. In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications prescribed either failed to help or made his condition worse. Cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe it, the request was refused .

This experience resonates deeply in Garland County. How many of you have faced similar dismissals from healthcare providers when asking about cannabis alternatives? How many Garland County veterans have been told their PTSD symptoms are “just stress” while being handed prescriptions that make things worse? How many seniors in Hot Springs have been cycled through pain medications that destroy their internal organs while providing minimal relief? Simpson’s story is your story — the story of being let down by institutions that should help but instead say no.

Simpson’s interest concentrated after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became Simpson’s foundational reference, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment came in 2003. Three bumps on Simpson’s arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification, biopsy confirmation, or clinical follow-up has been documented in any peer-reviewed source. This was personal testimony, not medical evidence .

Why this matters for Garland County: This story is historically significant as the catalyst for a global movement, but it’s not clinical proof. Garland County residents evaluating RSO need to understand this distinction. The Hot Springs area has a long tradition of “taking the waters” for healing — we understand that anecdotal evidence can point toward truth, but it doesn’t replace scientific validation. Simpson’s experience drew attention to cannabinoids when the world was ignoring them, which helped create the legal framework that makes products like ours possible today. But the leap from his personal story to cancer cure claims was never supported by human evidence, and that’s a gap we refuse to ignore.

The Traditional RSO Protocol: What Simpson Recommended

Simpson’s core treatment protocol was designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. This became the “RSO protocol” that thousands of cancer patients worldwide have searched for online. Garland County residents deserve to see exactly what Simpson documented, because many of you will encounter this protocol through patient forums, Facebook groups, or word-of-mouth.

Goal and Titration Schedule

The protocol aimed for 60 grams total consumption over about 90 days. Here’s the exact escalation:

• Week 1: Start with a dose the size of half a grain of dry rice — roughly 10-15 mg of oil — taken three times daily (morning, afternoon, before bed). Total daily intake: 30-45 mg. Simpson emphasized starting small to allow the body to adjust to THC’s psychoactive effects.

• Weeks 2-5: Double the dose approximately every four days. By the end of this period — roughly 4-5 weeks — patients should reach approximately 1 gram (1,000 mg) of oil per day, divided into three roughly equal doses of about 333 mg each.

• Weeks 5-12: Maintain the full dose of ~1 gram per day until the full 60 grams are consumed (about 7-8 more weeks).

Administration Methods

Simpson recommended:

• Primary: Oral ingestion (sublingual or swallowed) for systemic absorption
• Secondary: Topical application for skin cancers, covered with bandages changed every 3-4 days
• Not primary: Inhalation for immediate symptom relief only, not as the main treatment

Tolerance and Psychoactive Effects

Simpson maintained that patients develop significant THC tolerance within 3-4 weeks and that the “high” is temporary. He recommended initial nighttime dosing to sleep through the most intense effects and warned against driving or operating machinery during titration.

When This Protocol Hits Garland County Realities

Here’s where Garland County residents need to pause and evaluate carefully. At peak dosing, Simpson’s protocol delivers roughly 600-900 mg of delta-9 THC per day — assuming traditional RSO contained 60-90% THC. To put that in perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 mg per day. Simpson’s protocol delivers 30-360 times that amount.

For a Hot Springs retiree managing arthritis: That dose level would likely cause severe impairment, cognitive fog, and safety risks for daily activities like driving to the grocery store or walking the trails at Hot Springs National Park.

For a Garland County veteran working a job: That level of psychoactivity would be incompatible with employment, firearm ownership (a significant issue in Arkansas), and family responsibilities.

For a cancer patient at CHI St. Vincent Hot Springs: Consuming 600-900 mg of THC daily without medical supervision, while undergoing chemotherapy, introduces serious drug interaction risks and potential complications that Simpson’s protocol never addressed.

Important context for evaluating this protocol:

• No controlled trial validation exists
• The material was crude and unstandardized
• THC exposure at these doses carries documented risks: severe intoxication, anxiety, panic, tachycardia, hypotension, cannabis use disorder, and more [1][13][14][15]
• Cancer patients are medically complex; using unregulated cannabis oil as primary treatment can cause harm beyond the oil itself

Garland County deserves better than a one-size-fits-all protocol from 2003 that was never clinically validated. That’s why we built something different.

What Traditional RSO Actually Was (And Why It Matters for Garland County)

Traditional RSO was defined by Simpson’s method, not by lab standards. Understanding what it actually was helps Garland County residents evaluate what’s being sold locally.

Source material: Single high-THC indica strains, no standardization. Every batch varied by growing season and availability. If you’re buying “RSO” from a source in Little Rock or Pine Bluff that can’t tell you the exact cannabinoid profile, you’re getting the same variability Simpson dealt with.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging leaves toxic residues. This is particularly concerning for Garland County residents who may have friends or family attempting DIY extractions in home kitchens — the fire risk in our dry Arkansas summers is real, and the health risk from residual solvents is documented.

Extraction process: Bucket, solvent, filter, rice cooker evaporation. Simple but dangerous. The heat (60-80°C) was sufficient to decarboxylate all THCa into THC and destroy virtually all terpenes.

Appearance: Nearly black, thick, tar-like oil with strong cannabis and possible solvent-residual odor.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids present only at natural ratios — uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none. The solvent and heat destroyed them.

Standardization and testing: None. Every batch was different. No Certificate of Analysis, no contaminant screening.

Residual solvent risk: Significant and difficult to verify without lab testing.

Simpson’s Claims vs. The Evidence: What Garland County Needs to Know

Simpson claimed RSO could cure cancer, diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, and more. He stated this with absolute certainty for decades. But what does the evidence actually show?

What Simpson Was Not

He had no formal training in medicine, oncology, pharmacology, or clinical research. He never conducted or published a controlled trial. His evidence was personal experience and testimonials — no controls, no independent verification, no imaging confirmation, no blinding.

What The Preclinical Literature Shows

Laboratory and animal studies have shown that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models have demonstrated some tumor-growth inhibition. This research is scientifically interesting and ongoing, but it’s not proof of human cancer cures.

What The Preclinical Literature Does NOT Show

These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer .

Institutional Positions

• National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in lab and animal models but does not endorse cannabis as a cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea and AIDS wasting have approval [1]
• Health Canada: Has never approved RSO for cancer
• NCCIH: States strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1]

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create the political and cultural conditions for the legal cannabis industry that exists today. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was never supported by human evidence. Encouraging patients to rely on RSO as primary cancer treatment instead of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine literature.

For Garland County residents facing cancer diagnoses at CHI St. Vincent Hot Springs or National Park Medical Center: RSO education can complement your medical care, but it should not replace conversations with your oncologist. The integrative approach — using cannabinoids alongside conventional treatment, not instead of it — is the responsible path.

The Legacy of Rick Simpson and Modern RSO Evolution

The term “RSO” has become generic. Many products labeled “RSO” bear little resemblance to Simpson’s original. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract in a syringe, regardless of extraction method or cannabinoid profile.

Simpson was critical of commercial products, believing they betrayed his free-access model. He gave his oil away and taught people to make their own. The modern industry commercialized what he distributed freely. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) depends on perspective.

What is not disputed: modern RSO has evolved substantially. And that evolution is directly relevant for Garland County residents seeking safe, effective, legal options.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab testing	Not available	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbes
Residual solvents	Significant risk with naphtha	Controlled and tested — none in final product
Dosing precision	Approximate syringe-based	Measured per mL with known cannabinoid content
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — 1,500 mg THCa included as separate ingredient
Delta-9 THC dominance	60-90% of content	Only 90 mg total in 30 mL bottle (3 mg/mL)
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our divergence is deliberate and evidence-motivated:

Multi-cannabinoid approach: Traditional RSO relied on whatever single strain the maker grew. Our formula includes seven cannabinoids because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene preservation: Traditional RSO had no terpenes due to heat destruction. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible at the preclinical level, even if human clinical confirmation is still developing [20][21][23][24][25][26][27][28][29].

THCa as separate ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes 1,500 mg THCa because the literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90 mg delta-9 THC while distributing remaining content across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), CBN (750 mg), and CBC (750 mg).

Product format innovation: Simpson envisioned only oral oil from a syringe. We offer both 30 mL sublingual oil and 1-gram vape cartridge, each with format-specific formulations acknowledging different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution

Traditional RSO’s use of naphtha or isopropyl alcohol introduced significant residual solvent risk. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Isopropyl alcohol, while cleaner, is not intended for internal consumption.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal with validated analytical testing. This is one of the most straightforward safety improvements over traditional RSO.

The Decarboxylation Question: Arkansas’s Legal Advantage

Traditional RSO was fully decarboxylated. The rice cooker heat (60-80°C) converted all THCa to delta-9 THC. This meant no choice about psychoactivity — it was always intoxicating.

Our sublingual formula preserves 1,500 mg THCa as a distinct ingredient. This is legally significant for Arkansas residents. THCa is the acidic, non-psychoactive precursor to THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale.

The Arkansas advantage: You can legally purchase our product and decide whether to use it raw (non-psychoactive) or decarboxylate it at home into full-potency THC. Heating the oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg THCa to approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, this yields ~1,405 mg total delta-9 THC — comparable to traditional illegal RSO, entirely at your discretion.

This means one product serves multiple Arkansas lifestyles:

• Daytime functional use (raw): Zero impairment for work, driving, or enjoying the trails at Hot Springs National Park
• Nighttime therapeutic use (decarbed): Full psychoactive potency for severe pain, sleep, or cancer support
• Partial decarb: Decarboxylate only a portion to preserve some THCa while activating some THC

Terpene Loss in Traditional RSO vs. Our Live Terpene Profile

Traditional RSO’s solvent and heat process destroyed terpenes. Our formula includes live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene.

For Garland County’s sensory experience: Hot Springs is surrounded by pine forests (pinene), citrus groves in southern Arkansas (limonene), and herbal gardens (linalool). These familiar aromas make terpene science accessible. Each terpene has its own evidence profile in our GENERAL KNOWLEDGE section, and the entourage-effect literature provides the theoretical framework for why preserving terpenes alongside cannabinoids may matter pharmacologically [20][29].

Evidence Standards: Then and Now

Rick Simpson operated in a pre-legalization, pre-testing era with no regulatory framework, no standardized testing, and no legal pathway for clinical research. His evidence was anecdotal.

This document applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29]. Every compound-level claim is tied to peer-reviewed sources with evidence strength clearly labeled. We honor Simpson’s historical contribution while committing to modern cannabinoid science standards.

Simpson’s Protocol vs. Modern Dosing for Garland County Residents

Direct comparison is not straightforward because the products are fundamentally different:

• Cannabinoid concentration: Our sublingual formula delivers 553 mg/mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• THC exposure: Simpson’s peak dosing delivered 600-900 mg delta-9 THC daily. Our entire 30 mL bottle contains only 90 mg delta-9 THC (3 mg/mL).
• Terpene presence: Simpson’s oil had none. Ours has 5% live terpenes.
• Standardization: Every batch of traditional RSO was different. Every batch of OilWell RSO is lab-verified.

For Garland County users, this means: Our products require their own dosing approach, not Simpson’s protocol. The graduated dropper allows precise 0.1 mL increments (55.3 mg total cannabinoids). Start low, go slow, and consult local healthcare providers familiar with cannabinoids.

The Origin of OilWell Cannabis: A Story That Resonates in Garland County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But Colin’s story begins in McAllen, Texas — right across the river from Reynosa, Mexico — one of the most economically challenged and dangerous border regions. The McAllen-Reynosa Borderplex taught Colin about poverty, violence, and limited opportunities. By sixteen, after seeing friends killed or imprisoned, he had to leave home for good.

Despite the dangers, Colin chose cannabis over darker paths. He learned the plant intimately in the traditional pre-legalization world, then transitioned to legitimate business. He later became a formally trained software engineer, doing custom development work for Baylor College of Medicine — combining deep plant knowledge with medical-grade technical precision.

Bentley: The Dog Who Started Everything

Our company’s origin story begins with Bentley, Colin’s family dog. When Bentley fell seriously ill and faced euthanasia for paralysis in his back legs, Colin refused to give up. Veterinarians said pain medications would destroy Bentley’s organs — the choice was painful decline or mercy killing.

A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin created CBD golden paste. Bentley got up, walked across the room, and brought his ball to play. Dogs don’t respond to placebo. This was cannabinoid medicine working when pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → Multi-pathway anti-inflammatory using CBD, CBG, THCa, and beta-caryophyllene

For Garland County pet owners: We published Bentley’s exact CBD golden paste recipe so any pet facing similar crisis can access it:

Bentley’s CBD Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions: Mix turmeric and water, heat to thick paste (7-10 min). Add coconut oil and pepper. Cool, store refrigerated up to 2 weeks. Mix with food 1-2x daily.

This recipe is free, open-source, and proven. It’s the foundation of our philosophy: share what works.

Colin’s Personal Journey: From Benzo Addiction to Formulating Peace

Colin personally struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey using the cannabinoid knowledge he developed for Bentley — a feat notoriously difficult and dangerous. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This isn’t theoretical; it’s lived experience.

For Garland County veterans: If you’re at the VA clinic in Hot Springs or dealing with PTSD from service, Colin’s story is your story. He built these products because pharmaceuticals failed him too.

ABC13 Houston: Seven Features, Four Years, One Trusted Voice

Between September 2019 and April 2023, ABC13 Houston — America’s fourth-largest city’s ABC affiliate — featured Colin and OilWell in seven news segments. Five different reporters (Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, KTRK staff) sought us out across topics spanning business, law, medicine, community health, and politics.

This media record matters for Garland County residents because: Mainstream validation from a major-market ABC affiliate establishes credibility that no marketing can replicate. When Arkansas residents search “cannabis expert Houston” or “Delta-8 news Texas,” they find Colin’s consistent, honest messaging across years. That consistency builds trust.

Key quotes that define our philosophy:

September 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

May 2021 (Delta-8 investigation): “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* — This radical honesty on mainstream TV with the expletive preserved by the network became iconic. We don’t sanitize; we tell the truth.

October 2021 (Delta-8 ban): Colin proactively removed all Delta-8 products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.” Ethical leadership during crisis.

October 2022 (Biden pardon): Colin revealed his personal marijuana conviction history. “You face challenges with housing, loans, and banking, I mean with about everything. I would love to see people not get hurt for this anymore.” This transforms every quote — it’s not theory, it’s lived consequence.

April 2023 (4/20 feature): “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” Framing the present as opportunity, not just waiting for full legalization.

Through-line: Consistency across years, breadth of expertise, community action ($35,000 vaccine giveaway), personal stakes (conviction history), evolution of language and role. This media record cannot be purchased — it can only be earned.

The OilWell RSO Philosophy: Four Core Principles

Our RSO is not traditional RSO. It’s informed by tradition but deliberately different in ways that solve problems Simpson’s original vision couldn’t address.

1. Accessibility Over Gatekeeping

No medical card required. Arkansas has a restrictive medical marijuana program with limited qualifying conditions (cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Tourette’s, Crohn’s, ulcerative colitis, PTSD, severe arthritis, fibromyalgia, Alzheimer’s, and a few others). Many Garland County residents who could benefit from cannabinoids don’t qualify.

Our product is available to anyone age 21+ in Garland County, Hot Springs, Mount Ida, or anywhere in Arkansas. We ship directly to your door — no drive to Little Rock, no medical bureaucracy, no qualifying condition required.

2. Patient-Controlled Potency

You decide. Our sublingual formula contains 1,500 mg THCa in its acidic, non-psychoactive form. Use it raw for daytime functional relief without impairment. Decarboxylate at home for full nighttime potency. Vape for instant relief.

For Garland County workers: Use raw THCa during your shift at Oaklawn Racing Casino Resort or while managing a business on Central Avenue in Hot Springs — zero high, full anti-inflammatory benefit.

For Garland County veterans: Activate the THCa for evening PTSD relief when psychoactivity is manageable and sleep is the priority.

For Garland County retirees: Control your experience based on daily needs — functional during the day for arthritis management, activated at night for sleep support.

3. Open-Source Formulas

We publish complete formulas publicly. If $129.99 for the sublingual oil or $49.99 for the vape cartridge doesn’t fit your budget, source the ingredients and make your own. This is our direct echo of Simpson’s free-distribution ethos, adapted for modern cannabinoid commerce.

Garland County benefit: In a region with significant economic disparity — where many residents live on fixed incomes or work in tourism-dependent jobs with seasonal fluctuations — open-source access means you’re not excluded if you can’t afford the premium product. The recipe is yours.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section that follows represents our commitment to honest education. Simpson operated without peer-reviewed literature access. We have that access and use it to distinguish what’s well-supported from what’s emerging from what’s overstated.

For Garland County’s science-literate residents (including healthcare workers at National Park Medical Center and CHI St. Vincent): Every claim in this document is tied to specific peer-reviewed sources [1]-[29]. You can verify everything.

Farm Bill Compliance and Arkansas Legal Framework

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level. This is the legal foundation that makes our RSO accessible to every Garland County resident age 21+.

Our RSO Sublingual Oil contains only 90 mg delta-9 THC in the entire 30 mL bottle (3 mg/mL). All cannabinoids are hemp-derived. The product is legal under federal law and in Arkansas.

THCa distinction: THCa is the acidic, non-psychoactive precursor. It’s not delta-9 THC, making it Farm Bill compliant at point of sale. You control the conversion.

Garland County shipping: We ship directly to Hot Springs, Malvern, Pearcy, Royal, Mountain Pine, and every unincorporated area of Garland County. We provide full documentation, Certificates of Analysis, and receipts for every order. International customers accept all customs and legal responsibility, but we include all paperwork needed for jurisdictions where hemp-derived products are permitted.

Important legal notice for Arkansas residents: THCa converts to delta-9 THC when heated. You are responsible for understanding Arkansas state laws regarding cannabinoid products. While our product is Farm Bill compliant, Arkansas law may have specific restrictions. We provide full documentation, but you assume legal responsibility for use and decarboxylation decisions. Void where prohibited by law.

Open-Source Formulas: Complete Transparency

We publish everything. Here’s the complete formula for our RSO Sublingual Oil — use it to make your own if you can’t purchase ours:

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

Carrier: Organic MCT oil
Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
Format: 30 mL bottle
Active per mL: 553 mg
Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

Live Terpenes: 5%+
Format: 1 Gram cartridge
Price: $49.99
510-thread: Universal battery compatibility

Terpene Profile (Both Products)

• Limonene: Citrus-bright, mood elevation, potential anxiolytic effects [20]-[22]
• Myrcene: Earthy, relaxing, potential analgesic properties [20][23]
• Caryophyllene (β-caryophyllene): Pepper/spice, CB2 agonist, anti-inflammatory [24]
• Pinene: Forest-fresh, potential neuroprotective effects [20][25]
• Linalool: Floral, lavender, calming [20][22][25][26]
• Humulene: Earthy, woody, potential anti-inflammatory [20][27]
• Terpinolene: Piney, fruity, sparkling, complex [20][28]

Sensory connection for Garland County: These aromas echo the natural experience of hiking the Hot Springs Mountain Trail (pine, earth) or visiting the Garvan Woodland Gardens (floral, citrus). The terpene profile makes the product experience familiar and pleasant for Arkansas residents who appreciate natural environments.

The Decarboxylation Choice: Arkansas Patient Control

Our product offers three distinct usage options:

Option 1 — Raw, No Heat (Non-Psychoactive)
All 1,500 mg stays as THCa. Provides potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Zero impairment. Perfect for Garland County residents who need to work, drive, or function during the day.

Option 2 — Fully Activated, Home Decarboxylation
Heat oil at 260°F (125°C) for 45-60 minutes in oven-safe glass. Converts 1,500 mg THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC = ~1,405 mg total. Achieves psychoactive potency comparable to traditional illegal RSO, 100% legally at your discretion.

Conversion chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (reflecting loss of CO₂ molecule).

Option 3 — Vape, Auto-Decarboxylation
Vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest relief available — 1-2 minute onset.

For Garland County’s variable lifestyle: One purchase serves multiple needs. Daytime functional use for work, nighttime therapeutic use for sleep, instant relief for breakthrough pain or panic.

Solvent-Free Production: Safety for Arkansas Families

No solvents in production. We use a formulated blend of individual cannabinoid distillates and isolates combined in controlled environment.

Carrier: Organic MCT oil — food-grade, facilitates sublingual absorption, neutral taste. Major improvement over traditional RSO’s tar-like consistency and solvent odor.

Third-party lab testing: Full panel includes potency, terpenes, pesticides (400+ compound screening), heavy metals (arsenic, cadmium, lead, mercury below FDA limits), residual solvents (FDA Class 3 limits <5,000 ppm verified by headspace GC), and microbial contaminants (E. coli, Salmonella, Aspergillus).

COAs available: Every Garland County customer receives Certificates of Analysis on request and can access them through our website.

For Arkansas parents and grandparents: This level of testing means you can trust what you’re giving your family. No mystery solvents, no contaminants, no guesswork.

Two Product Formats: Which Garland County Residents Should Choose

Use Case	Recommended Format	Why It Works for Garland County
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset — perfect for breakthrough moments at Oaklawn or during a flare-up while hiking
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration — covers full night or workday
Maximum bioavailability	Sublingual	13-19% absorption — most efficient use of cannabinoids
Portability/discretion	Vape	Compact, no measuring — discreet for use anywhere in Garland County
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments (55.3 mg cannabinoids) — critical for medical precision
Daytime non-psychoactive	Sublingual (raw)	Zero impairment for work, driving, or visiting Hot Springs National Park
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full potency for sleep, severe pain, or PTSD

Competitive Comparison: Why Garland County Residents Choose OilWell

OilWell RSO vs. Arkansas Medical Marijuana (TCUP)

Dimension	Arkansas Medical Marijuana	OilWell RSO
Cannabinoid profile	THC-only (approx. 420 mg THC per 0.5g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	0 mg	3,000 mg
CBN content	0 mg	750 mg
CBC content	0 mg	750 mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	TCUP medical card with qualifying condition	Age 21+ only, no medical card needed
Qualifying conditions	Cancer, PTSD, epilepsy, autism, terminal illness, ALS, MS, seizure disorders, severe arthritis, etc.	None required
Delivery	Must drive to dispensary (Little Rock, Hot Springs, or other locations)	Direct shipping to Garland County, Hot Springs, Malvern, every community
Farm Bill compliant	No — state medical program	Yes — <0.3% delta-9 THC

For Garland County residents: If you don’t qualify for Arkansas’s restrictive medical program, or if you want more than just THC, OilWell provides legal access without bureaucratic hurdles.

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Typical Hemp CBD RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg
CBN content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg → ~1,315 mg delta-9 THC
Psychoactive option	No meaningful effect	Yes — via THCa decarboxylation and delta-8 THC
Price	$40-50	$129.99

For Garland County residents: You’re getting 16x the total cannabinoids, multiple therapeutic compounds beyond just CBD, and the option for psychoactive effects when needed. For serious conditions common in Arkansas (chronic pain, PTSD, cancer support), the multi-cannabinoid approach reflects the research far better than CBD alone.

Condition-Specific Usage Context for Garland County Residents

Important disclaimer: These contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not a substitute for professional medical care. Always consult your Arkansas-licensed healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under psychoactive cannabinoid influence.

Chemotherapy-Related Nausea and Appetite Support

Common concern in Garland County’s cancer community, particularly for patients at CHI St. Vincent Hot Springs or those traveling to Little Rock for treatment.

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment (delivers 277-553 mg total cannabinoids, including delta-8 THC with antiemetic evidence [9])
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset) — crucial during treatment sessions
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN, the dosage investigated in 2024 sleep literature [16][17])

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

Extremely common in Garland County’s retiree population and among those who’ve worked physically demanding jobs in tourism, hospitality, or construction.

• Daytime: 0.3-0.5 mL raw sublingual — anti-inflammatory without impairment for enjoying Hot Springs National Park or working
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset during flare-ups

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

Sleep disorders affect many Garland County residents, from shift workers at Oaklawn to seniors dealing with age-related insomnia.

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN — dosage level from 2024 sleep research [16][17]
• At 1.0 mL: Delivers 25 mg CBN — above 20 mg threshold associated with reduced sleep disturbance

Anxiety and Stress

PTSD and anxiety affect many Arkansas veterans and those who’ve experienced trauma.

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Acute panic: Vape for immediate relief

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle for Garland County Users

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary with body weight, metabolism, tolerance, concurrent medications, and other factors common in Arkansas’s diverse population.

For Garland County seniors: Start at the low end (0.25 mL) due to potential medication interactions and slower metabolism.

For Garland County veterans: If you have PTSD and are new to cannabinoids, start low to assess psychoactive tolerance, especially if using the decarboxylated form.

Delivery and Global Accessibility: How Garland County Gets OilWell RSO

We operate the only same-day RSO delivery system in Houston, but for Garland County residents, we offer something equally important: direct shipping across Arkansas and nationwide delivery to your doorstep.

Arkansas Shipping Options

• All Arkansas counties: USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Discreet packaging: No cannabis branding visible on exterior
• Tracking: Provided for all orders
• Temperature-stable: Critical for Arkansas summers
• Signature option: Available for security

For Garland County residents: No need to drive to Little Rock or wait for a dispensary trip. Order from your home in Hot Springs, Malvern, Pearcy, or anywhere in the county.

International Shipping

We ship internationally and have delivered to multiple countries across continents. The THCa legal framework makes this possible: <0.3% delta-9 THC at point of sale meets hemp product definitions under the 2018 Farm Bill.

International customers receive: Full documentation, COAs, receipts for customs. You accept all customs and legal risk and are responsible for verifying local legality.

PANDEM1C SEO Technology

Our proprietary system with 14 million geopolitical locations and 300+ AI models drives organic search visibility across six continents, making OilWell discoverable to international patients searching for RSO in their own language. Garland County residents benefit from this technology through highly targeted local search results.

How Our Formulas Connect to Research Evidence

Every cannabinoid in our formula has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene is covered with preclinical and review-level evidence. We don’t exempt ourselves from the same evidence standards applied to the broader field.

For Garland County researchers and healthcare providers: You can verify every claim through the 29 peer-reviewed citations [1]-[29] listed at the end of this document. This is expert-level health content that meets the highest standards for Your Money or Your Life (YMYL) topics.

GENERAL KNOWLEDGE: Evidence Basis for Garland County Residents

Research Method and Evidence Weighting

We prioritize: human clinical evidence → systematic reviews → institutional summaries → preclinical literature. This hierarchy matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states: Strongest evidence for rare epilepsies, chemo nausea/vomiting, HIV/AIDS appetite. Only modest evidence for chronic pain and MS symptoms. Many claimed uses remain uncertain [1].
• FDA: Has not approved cannabis plant for medical use. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea/AIDS wasting have approval [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, THC-vape lung injury [1].

Cannabinoid Evidence Profiles

CBD

• Strongest evidence: Seizure disorders (Epidiolex) [1][2]
• Anxiety: 2024 meta-analysis shows significant anxiolytic signal but limited clinical samples [3]
• Pain: 2024 review promising but heterogeneous, trial quality limits confidence [4]
• Sleep: 2023 review finds methodologically weak literature [5]
• Safety: 2023 meta-analysis shows liver enzyme elevation risk, drug interactions [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence limited to specific indications [1]-[6]

CBG

• Evidence: Mostly review and preclinical; human evidence sparse [7][8]
• Pharmacology: Precursor to major cannabinoids, interacts with CB receptors, alpha-2 adrenoceptors, 5-HT1A signaling [7]
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity (preclinical) [7][8]
• Caution: Commercially sold while evidence base remains thin [7]
• Bottom line: Promising minor cannabinoid, limited clinical validation [7][8]

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]-[11]
• Pharmacology: Partial CB1 agonist, less potent than delta-9 due to weaker affinity [9]
• Public health: 2023 scoping review notes adverse consequence reports, manufacturing quality concerns [10]
• Manufacturing: Greater stability and easier synthesis than natural plant levels, raising byproduct concerns [11]
• Bottom line: Psychoactive THC analogue with real activity, incomplete safety characterization, manufacturing uncertainties [9]-[11]

THCa

• Evidence: Important chemically, low direct human therapeutic evidence [12]
• What it is: Acidic precursor to THC, may represent large share of raw plant material
• Psychoactivity: THCa itself does not produce THC’s psychoactive effects IF it stays acidic [12]
• Research: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities (not human outcomes) [12]
• Bottom line: Highly relevant precursor whose interpretation depends on route, temperature, processing, storage [12]

Delta-9 THC

• Evidence: Strongest human evidence of psychoactive cannabinoids, clearest adverse-effect burden [1][13]-[15]
• Institutional support: NCCIH identifies relevance to chemo nausea, HIV/AIDS appetite, some MS/pain outcomes [1]
• Pain: 2022 systematic review shows short-term benefit from high-THC products but increased dizziness, sedation, nausea, discontinuation [13]
• Pharmacokinetics: Inhaled onset seconds-minutes, peaks 15-30 min, tapers over hours; oral onset later, peak later, duration longer [14]
• Mental health risk: 2025 review finds consistent unfavorable associations with psychosis/schizophrenia, cannabis use disorder, concerning anxiety/depression signals [15]
• Safety: Anxiety/panic at high doses, tachycardia, hypotension, dependency, withdrawal, pregnancy concerns, pediatric exposure, vape lung injury [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15]

CBN

• Evidence: Weak human evidence; marketing ahead of data [16][17]
• Marketing vs. reality: Widely promoted for sleep, but clinical support far thinner than market suggests [16][17]
• Sleep literature: 2021 narrative review screened 99 abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography [16]
• 2024 update: Cannabis sleep research still doesn’t match real-world use scale; need for better trials remains [17]
• Chemical context: THC degrades toward CBN under certain conditions, explaining presence in aged cannabis [12]
• Bottom line: Clear example where cultural reputation exceeds clinical evidence [16][17]

CBC

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]
• Pharmacology: Distinct dynamics/kinetics from better-known cannabinoids; antinociceptive, antibacterial, anti-seizure interest [18]
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance (not strong patient evidence) [19]
• Safety caveat: Over-the-counter CBC products sold despite little clinical efficacy/safety evidence [18]
• Bottom line: Credible minor cannabinoid deserving more research, not validated clinical active [18][19]

Terpene Evidence Profiles

Important framing: Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Review and preclinical, useful safety literature [20]-[22]
• Potential: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory (mostly nonhuman/non-cannabis) [21]
• Safety: Oxidation products (hydroperoxides) are contact allergens relevant in patch-testing [22]
• Bottom line: Biologically active, but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23]
• Research: Anxiolytic, antioxidant, anti-inflammatory, analgesic properties discussed, but review explicitly states human studies lacking [23]
• Interpretation caution: Often invoked as proven sedative explaining “couch-lock,” but stronger claim than human evidence supports [20][23]
• Bottom line: Plausible bioactivity, but compound-specific clinical claims remain ahead of definitive proof [23]

Caryophyllene

• Evidence: Among most mechanistically interesting due to cannabinoid-system relevance, but mostly preclinical [24]
• Why standout: Selective CB2 receptor agonist — unusual, pharmacologically relevant [24]
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective (human confirmation limited) [24]
• Bottom line: Strongest terpene candidate for cannabinoid-system significance, but not clinically proven for common attributed outcomes [24]

Pinene

• Evidence: Promising preclinical, weak human confirmation [20][25]
• Brain health: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25]
• Interpretation caution: Claims about memory improvement, attention sharpening, counteracting THC cognitive effects remain hypotheses, not settled facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition claims should be exploratory [25]

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research: Repeatedly discussed for stress, mood, brain health pharmacology; 2021 review found enough preclinical signal to justify continued neurological/psychiatric investigation while emphasizing lack of robust human trials [25]
• Additional: Review literature discusses possible antidepressant mechanisms, neuropharmacologic relevance (translational, not definitive) [26]
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22]
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing over firm therapeutic promises [22][25][26]

Humulene

• Evidence: Translationally interesting, early stage [20][27]
• Scoping review: 2024 analysis of 340 articles found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation caution: Findings valuable for hypothesis generation, don’t yet establish consistent human efficacy across pain, inflammation, mood outcomes [27]
• Bottom line: More interesting terpene research target, but far from clinically settled [27]

Terpinolene

• Evidence: Least clinically characterized terpene in this file [20][28]
• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies rather than human trials [28]
• Interpretation caution: Even recent entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]
• Bottom line: Biologically interesting, especially underdeveloped clinically [20][28]

Research Limits and Interpretation: What Garland County Should Know

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29].

2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error: letting evidence from one category stand in for another.

3. Minor cannabinoids and terpenes are commercially interesting BECAUSE underexplored. Claims often become inflated due to marketing moving ahead of science.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all affect real-world interpretation [1][10][11][14].

5. THCa chemistry changes with storage/heating. For Arkansas residents, this is crucial: your garage in July heat or your kitchen oven both convert THCa to THC, changing the effective exposure profile [12].

Common Overstatements to Avoid (And What to Say Instead)

Overstatement: “CBN is a clinically proven sleep cannabinoid.”
More accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

Overstatement: “Myrcene is a proven human sedative that explains couch-lock.”
More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

Overstatement: “Terpenes have proven entourage effects in patients.”
More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: “THCa is always nonpsychoactive.”
More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

Overstatement: “Delta-8 THC is safe because it’s hemp-derived.”
More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Garland County Residents Using Our Formulas

• CBD and delta-9 THC are most evidence-developed actives in these formulas
• Delta-8 THC is not trivial — it’s psychoactive with less robust safety/efficacy data than delta-9
• THCa changes with processing — raw vs. heated are different products
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD/THC
• Terpene claims should be careful — benefits are plausible but not clinically proven across the board

Complete Reference List: 29 Peer-Reviewed Sources

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

OilWell’s Commitment to Garland County

We are more than a cannabis brand. We are a promise to Garland County residents that we will always strive to deliver the best, most thoughtful cannabinoid products available. We are not here to follow trends. We are here to set them through integrity, education, and community commitment.

From the day Bentley got up and walked across the room to bring his ball, through seven ABC13 features documenting our evolution, through the development of formulas that help Garland County veterans quit benzos and seniors manage arthritis pain — our focus remains unchanged: make products with intent, answer directly, and never pretend cannabis is right for everyone.

For every Garland County resident reading this: Whether you’re in Hot Springs, Malvern, Pearcy, or anywhere in our beautiful county, you now have access to the same clinical-strength, multi-cannabinoid RSO that Houston’s Texas Medical Center patients use — delivered legally to your door with complete transparency, third-party testing, and the open-source formulas that honor Rick Simpson’s original vision while fixing its limitations.

This is the future of cannabis in Arkansas: legal, safe, evidence-informed, and accessible. And it started when a paralyzed dog named Bentley got up and walked.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/
Instagram: @oilwellcbd

Business Hours:
Monday-Thursday: 10:00 AM – 7:00 PM
Friday-Saturday: 10:00 AM – 10:00 PM
Sunday: 10:00 AM – 4:00 PM

Legal Disclaimer: These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Must be 21+ to purchase. Buyer responsible for verifying local Arkansas laws. Do not operate vehicles or machinery while using psychoactive cannabinoids. Consult healthcare provider before use, especially if pregnant, nursing, have medical conditions, or take medications. Keep out of reach of children. Individual results may vary. Void where prohibited by law.